Routes of Administration

1. Navigating Enteral, Parenteral, and Topical Routes

The route of administration is the path by which a drug is brought into contact with the body. Choosing the correct route is a critical clinical decision that directly impacts the drug's onset of action, bioavailability, and therapeutic effect. For the Medical Assistant (MA) exam, you must understand the differences between major routes, the specific techniques required, and the safety considerations associated with each.^[1]

Why this matters on exams and in practice:

• Medication errors often involve selecting the wrong route or using an incorrect technique.
• Employers and clinical supervisors expect MAs to be proficient in administering oral, topical, and injectable medications safely.
• Understanding routes helps you anticipate patient education needs (e.g., how a transdermal patch works vs. an oral tablet).

Quick Comparison Table

2. Absorption Pathways and First-Pass Effect by Route

Enteral Routes (Via the GI Tract)

• Oral (PO): Most common and convenient route. Subject to the first-pass effect, where the drug is metabolized in the liver before reaching systemic circulation, reducing bioavailability.^[1]
• Sublingual (SL) & Buccal: Drug dissolves under the tongue or against the cheek. These routes bypass the GI tract and first-pass metabolism, providing rapid absorption into the bloodstream.^[7]
• Rectal (PR): Used when the patient is vomiting, unconscious, or unable to take oral medications. Absorption is erratic but partially bypasses the liver.

Parenteral Routes (By Injection)

• Intradermal (ID): Injected into the dermis (just below the epidermis). Small volume (0.1 mL). Used for sensitivity tests (tuberculosis, allergy).^[2]
• Subcutaneous (SubQ): Injected into the fatty tissue layer above the muscle. Common for insulin, heparin, and Lovenox. Small volume (0.5–1.5 mL).^[4]
• Intramuscular (IM): Injected into deep muscle tissue. Common sites: Ventrogluteal (safest/ preferred), Vastus Lateralis (infants), and Deltoid (adults, small volumes).^[6]
• Intravenous (IV): Administered directly into the vein. Provides 100% bioavailability and immediate onset. High risk for complications (infection, air embolism, phlebitis).^[2]

Topical Routes (Applied to Surface)

• Transdermal: Patch placed on skin for systemic effect (e.g., nicotine, nitroglycerin, fentanyl).
• Inhalation: Delivered via inhaler or nebulizer for local lung effects (e.g., albuterol).
• Otic/Ophthalmic: Drops or ointments applied to the ear or eye.

3. Medication Safety Framework and Injection Best Practices

The "Rights" of Medication Administration

Standard safety framework used in all healthcare settings to prevent errors. Commonly tested as the "6 Rights" or "10 Rights."^[3]

1. Right Patient: Use two identifiers (name + DOB or medical record number).
2. Right Drug: Compare the medication label to the MAR three times.
3. Right Dose: Calculate correctly; double-check high-alert meds.
4. Right Route: Verify the route is appropriate for the medication.
5. Right Time: Check the frequency and schedule.
6. Right Documentation: Document immediately after administration.

Parenteral Administration Techniques

IM Injection (Z-Track Method): Used to prevent medication leakage into subcutaneous tissue, reducing irritation and staining.^[6]

1. Draw up the medication.
2. Change the needle (optional, but best practice).
3. Pull the skin laterally (about 1 inch) and hold.
4. Inject at a 90-degree angle.
5. Wait 10 seconds before withdrawing the needle.
6. Release the skin after removing the needle to create a zigzag path.

SubQ Injection (Heparin/Insulin):^[4][8]

• Pinch a 1-inch fold of skin.
• Insert needle at a 45- to 90-degree angle (depending on needle length and patient size).
• Do not aspirate (check recent guidelines; not recommended for SubQ).
• Do not massage/rub after heparin injection (risk of hematoma).
• Rotate injection sites (abdomen, thighs, arms).

4. Optimal Intramuscular Injection Sites and Volumes

• Deltoid: 3 fingers below the acromion process. Max volume: 1 mL (may be up to 2 mL depending on muscle mass).
• Vastus Lateralis: Anterior lateral thigh, middle third. Preferred site for children under 3 years old.
• Ventrogluteal: Over the gluteus medius muscle, away from major blood vessels and the sciatic nerve.^[6]
• Dorsogluteal: Rarely used due to high risk of injury to the sciatic nerve and superior gluteal artery.

5. Pre- and Post-Administration Verification and Monitoring

• Patient Identification: Always confirm using two identifiers before any administration.^[5]
• Site Assessment: Inspect for inflammation, bruising, infection, or lesions before injecting or applying a topical agent.
• Allergy Verification: Confirm the patient has no known allergies to the medication.
• Post-Administration Monitoring: Observe for adverse reactions (e.g., anaphylaxis, bleeding, or site irritation). Document the patient's response.

6. Patient Education for Self-Administration and Device Use

• Patient Education: Teach patients how to self-administer SubQ injections (rotate sites, use a sharps container).^[8]
• Transdermal Patches: Advise patients to remove the old patch before applying a new one to prevent overdose. Rotate application sites.
• Inhalers: Instruct patients on proper inhaler technique (shake, exhale, activate while inhaling deeply, hold breath).

7. Preventing Needlestick Injuries, Anaphylaxis, and Other Risks

High-Yield Warnings

• Needlestick Injuries: Never recap a used needle. Dispose of sharps immediately in an approved sharps container.^[5]
• Air Embolism (IV): Ensure all air is removed from IV tubing and syringes before administration.
• Hematoma: Apply firm pressure to the injection site after IM/SubQ. Avoid massaging heparin sites.^[4]
• Anaphylaxis: Always ask about allergies. Be prepared with emergency equipment (epinephrine, EpiPen).
• Medication Errors: If an error occurs, follow facility policy immediately. Document accurately, not to cover the error, but to ensure patient safety.

8. Mnemonics and Frequently Tested Medication Facts

Memory Aids (Mnemonic):

• Injection Angles: "ID is 'in the Dermis' (15° angle), SubQ is 'Subcutaneous Fat' (45/90° angle), IM is 'Into Muscle' (90° angle)."
• Insulin Order: "Clear before Cloudy" (Regular [clear] before NPH [cloudy]).^[8]
• Ear Drops: "Adults pull Up and Back; Children pull Down and Back."
• First-Pass Effect: If a test question asks "Which route bypasses the liver?" — think Sublingual, Buccal, Rectal (partial), IV, IM, SubQ.

Commonly Tested Concepts:

1. Z-track Method: Purpose is to prevent irritation and seal the medication in the muscle.
2. Maximum Volume for IM: Deltoid (0.5–1 mL), Gluteal/Vastus (2–5 mL for large adults).
3. Mixing Insulin: Draw up the clear insulin first, then the cloudy insulin.
4. Intradermal injection: Bevel up, 10–15 degree angle, look for small bleb (wheal) formation.

9. References and Sources

1. Silvestri, L. A., & Silvestri, A. E. (2020). Saunders Comprehensive Review for the NCLEX-RN Examination (8th ed.). Elsevier. https://evolve.elsevier.com/cs/product/9780323582414
2. Potter, P. A., Perry, A. G., Stockert, P., & Hall, A. (2021). Fundamentals of Nursing (10th ed.). Elsevier. https://xpdf4u.com/reviews/A10EFP/995106/4991876-potter-and-perry-fundamentals-of-nursing-10th-edition
3. The Joint Commission. (2023). National Patient Safety Goals. https://www.jointcommission.org/standards/national-patient-safety-goals/
4. Mayo Clinic. (2022). Heparin (Subcutaneous Route): Description and Brand Names. https://www.mayoclinic.org/drugs-supplements/heparin-intravenous-route-subcutaneous-route/description/drg-20068726
5. Occupational Safety and Health Administration (OSHA). (2019). Bloodborne Pathogens and Needlestick Prevention. https://www.ncbi.nlm.nih.gov/books/NBK570561/
6. Cocoman, A., & Murray, J. (2008). Intramuscular injections: a review of best practice for mental health nurses. Journal of Psychiatric and Mental Health Nursing, 15(5), 415-422. https://doi.org/10.1111/j.1365-2850.2007.01210.x
7. Antonacci, G., & Dunning, J. (2015). Sublingual and buccal drug administration. Nursing Standard, 29(25), 46-51. https://pubmed.ncbi.nlm.nih.gov/39004586/
8. American Diabetes Association. (2022). Standards of Medical Care in Diabetes—2022. Diabetes Care, 45(Supplement 1), S1–S264. https://doi.org/10.2337/dc22-S009